| 2024-11-15 |
复牌提示：
2024-11-14 19:50:00 停牌，复牌日期 2024-11-18 00:00:01
|
| 2024-11-15 |
详情>>
内部人交易：
CARREL MICHAEL H等共交易12笔
|
| 2024-11-07 |
详情>>
股本变动：
变动后总股本5110.92万股
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.24美元,归母净利润-1223.4万美元,同比去年增长3.38%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-0.24美元,归母净利润-1221.3万美元,同比去年增长26.38%
|
| 2024-04-30 |
详情>>
业绩披露：
2024年一季报每股收益-0.38美元,归母净利润-1911.2万美元,同比去年增长-106.66%
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-0.12美元,归母净利润-608.8万美元,同比去年增长89.80%
|
| 2024-02-29 |
详情>>
业绩披露：
2021年年报每股收益-1.86美元,归母净利润-8006.7万美元,同比去年增长-45.8%
|
| 2024-02-22 |
股东大会：
将于2024-03-22召开股东大会
会议内容 ▼▲
- 1.To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated January 8, 2024 (such agreement, as it may be amended, modified or supplemented from time to time, the “Merger Agreement”), by and among Axonics, Boston Scientific Corporation, a Delaware corporation (“Boston Scientific”), and Sadie Merger Sub, Inc., a Delaware corporation (“Merger Sub”). Upon the terms and subject to the conditions of the Merger Agreement, Boston Scientific will acquire Axonics via a merger of Merger Sub with and into Axonics, with the separate corporate existence of Merger Sub thereupon ceasing and Axonics continuing as the surviving company and a wholly owned subsidiary of Boston Scientific (the “Merger”);
2.To consider and vote on the proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Axonics’ named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the “Compensation Proposal”);
3.To consider and vote on any proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the “Adjournment Proposal”).
|
| 2023-10-31 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.26美元,归母净利润-1266.2万美元,同比去年增长79.02%
|
| 2023-10-30 |
财报披露：
美东时间 2023-10-30 盘后发布财报
|
| 2023-07-31 |
详情>>
业绩披露：
2023年中报每股收益-0.34美元,归母净利润-1659万美元,同比去年增长62.39%
|
| 2023-07-31 |
详情>>
业绩披露：
2022年中报每股收益-0.98美元,归母净利润-4411.1万美元,同比去年增长7.43%
|
| 2023-05-02 |
详情>>
业绩披露：
2023年一季报每股收益-0.19美元,归母净利润-924.8万美元,同比去年增长59.20%
|
| 2023-05-01 |
股东大会：
将于2023-06-26召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors named in the Proxy Statement to serve until our Annual Meeting to be held in 2024, or until their successors are duly elected and qualified or until his or her earlier resignation or removal.
2.To ratify the selection of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
3.To approve, on an advisory basis, the compensation of our named executive officers.
4.To consider and act upon such other business as may properly come before the Annual Meeting or any postponements or adjournments thereof.
|
| 2023-03-01 |
详情>>
业绩披露：
2022年年报每股收益-1.28美元,归母净利润-5969.8万美元,同比去年增长25.44%
|
| 2022-11-09 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.31美元,归母净利润-6036.3万美元,同比去年增长6.99%
|
| 2022-04-15 |
股东大会：
将于2022-05-25召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors named in the Proxy Statement to serve until our Annual Meeting to be held in 2023, or until their successors are duly elected and qualified or until his or her earlier resignation or removal.
2.To ratify the selection of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
3.To approve, on an advisory basis, the compensation of our named executive officers.
4.To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended (our “Charter”) to increase the number of authorized shares of our capital stock from 60,000,000 shares to 85,000,000 shares, and the number of authorized shares of our common stock from 50,000,000 shares to 75,000,000 shares.
5.To approve an amendment to our Charter to (i) reduce the vote required for our stockholders to amend, alter or repeal our Amended and Restated Bylaws from (A) 66 2/3% in voting power of the outstanding shares of our capital stock entitled to vote thereon, to (B) a majority in voting power of the outstanding shares of our capital stock entitled to vote thereon, and (ii) reduce the vote required to amend, repeal, or adopt any provisions of our Charter from (A) the affirmative vote of the holders of at least 66 2/3% of the voting power of the shares of our outstanding stock entitled to vote thereon, voting together as a single class, to (B) the affirmative vote of a majority of the voting power of the shares of our outstanding stock entitled to vote thereon, voting together as a single class.
6.To approve an amendment to our 2018 Omnibus Incentive Plan (the “2018 Plan”) to increase the number of shares of our common stock available for the grant of equity compensation awards thereunder by 3,100,000 shares.
7.To consider and act upon such other business as may properly come before the Annual Meeting or any postponements or adjournments thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-23召开股东大会
会议内容 ▼▲
- 1.To elect the six directors named in the Proxy Statement to serve until our Annual Meeting to be held in 2022, or until their successors are duly elected and qualified or until his or her earlier resignation or removal.
2.To ratify the selection of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
3.To approve, on an advisory basis, the compensation of our named executive officers.
4. To hold an advisory vote on the frequency of future advisory votes to approve compensation of our named executive officers.
5. To consider and act upon such other business as may properly come before the Annual Meeting or any postponements or adjournments thereof.
|
| 2020-04-29 |
股东大会：
将于2020-06-24召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect the seven directors named in the Proxy Statement to serve until our Annual Meeting to be held in 2021, or until their successors are duly elected and qualified.
2.Ratification of Selection of Independent Registered Public Accounting Firm. To ratify the selection of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
3.Other Business. To consider and act upon such other business as may properly come before the Annual Meeting or any postponements or adjournments thereof.
|
| 2019-07-09 |
股东大会：
将于2019-08-19召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect the eight directors named in the Proxy Statement to serve until our Annual Meeting to be held in 2020, or until their successors are duly elected and qualified.
2.Ratification of Selection of Independent Registered Public Accounting Firm. To ratify the selection of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
3.Other Business. To consider and act upon such other business as may properly come before the Annual Meeting or any postponements or adjournments thereof.
|